1. Home
  2. BAND vs RGNX Comparison

BAND vs RGNX Comparison

Compare BAND & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bandwidth Inc.

BAND

Bandwidth Inc.

HOLD

Current Price

$17.91

Market Cap

395.6M

Sector

Technology

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.53

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAND
RGNX
Founded
2000
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.6M
418.1M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
BAND
RGNX
Price
$17.91
$8.53
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$20.40
$28.75
AVG Volume (30 Days)
404.0K
741.4K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
$204,113,000.00
$10,393,000.00
Revenue This Year
$15.34
$50.05
Revenue Next Year
$7.89
$23.31
P/E Ratio
N/A
N/A
Revenue Growth
25.26
126.48
52 Week Low
$11.33
$5.04
52 Week High
$18.63
$16.19

Technical Indicators

Market Signals
Indicator
BAND
RGNX
Relative Strength Index (RSI) 71.51 48.10
Support Level $14.98 $7.81
Resistance Level $18.63 $9.28
Average True Range (ATR) 0.83 0.46
MACD 0.17 0.09
Stochastic Oscillator 85.77 68.66

Price Performance

Historical Comparison
BAND
RGNX

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: